DYN
Price
$15.50Alerts
Change
-$0.53 (-3.31%)
Updated
Nov 20 closing price
Capitalization
3.37B
102 days until earnings call
Intraday BUY SELL Signals
PTCT
Price
$56.42Alerts
Change
-$1.91 (-3.27%)
Updated
Nov 20 closing price
Capitalization
5.46B
93 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DYN vs PTCT

DYN vs PTCT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DYN vs. PTCT commentary
Nov 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Hold and PTCT is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for DYN with price predictions
Nov 20, 2026

DYN sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for DYN moved below the 200-day moving average on October 26, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for DYN moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 33 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 87%.

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DYN as a result. In 65 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.

The Moving Average Convergence Divergence Histogram (MACD) for DYN turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 35 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 85%.

DYN moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DYN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 10-day moving average for DYN crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 83%.

Following a +7.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where DYN advanced for three days, in 237 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

DYN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 226 of 248 cases where DYN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.806) is normal, around the industry mean (3.596). P/E Ratio (-5.543) is within average values for comparable stocks, (-1.186). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.158). Dividend Yield (0.000) settles around the average of (131.631) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (443.347).

The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. DYN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 96 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DYN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for PTCT with price predictions
Nov 20, 2026

PTCT's RSI Oscillator dives oversold zone

The RSI Indicator for PTCT moved into overbought territory on November 20, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +13.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where PTCT advanced for three days, in 217 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

The Aroon Indicator entered an Uptrend today. In 175 of 228 cases where PTCT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PTCT as a result. In 67 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.

The Moving Average Convergence Divergence Histogram (MACD) for PTCT turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 30 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.

PTCT moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PTCT crossed bearishly below the 50-day moving average on November 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 62%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PTCT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

PTCT broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-33.028) is normal, around the industry mean (3.596). PTCT has a moderately low P/E Ratio (-97.672) as compared to the industry average of (-1.186). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.158). Dividend Yield (0.000) settles around the average of (131.631) among similar stocks. P/S Ratio (6.094) is also within normal values, averaging (443.347).

The Tickeron Profit vs. Risk Rating rating for this company is 64 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 72 (best 1 - 100 worst), indicating slightly worse than average price growth. PTCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
DYN vs PTCT: Fundamental Ratings
DYN
PTCT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
1
Undervalued
PROFIT vs RISK RATING
1..100
9664
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
7372
P/E GROWTH RATING
1..100
21100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PTCT's Valuation (1) in the Biotechnology industry is somewhat better than the same rating for DYN (42) in the Electric Utilities industry. This means that PTCT’s stock grew somewhat faster than DYN’s over the last 12 months.

PTCT's Profit vs Risk Rating (64) in the Biotechnology industry is in the same range as DYN (96) in the Electric Utilities industry. This means that PTCT’s stock grew similarly to DYN’s over the last 12 months.

DYN's SMR Rating (98) in the Electric Utilities industry is in the same range as PTCT (100) in the Biotechnology industry. This means that DYN’s stock grew similarly to PTCT’s over the last 12 months.

PTCT's Price Growth Rating (72) in the Biotechnology industry is in the same range as DYN (73) in the Electric Utilities industry. This means that PTCT’s stock grew similarly to DYN’s over the last 12 months.

DYN's P/E Growth Rating (21) in the Electric Utilities industry is significantly better than the same rating for PTCT (100) in the Biotechnology industry. This means that DYN’s stock grew significantly faster than PTCT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DYNPTCT
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 14 days ago
84%
Bullish Trend 19 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
89%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
COMPARISON
Comparison
Nov 22, 2026
Stock price -- (DYN: $15.50 vs. PTCT: $56.42)
Brand notoriety: DYN and PTCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 91% vs. PTCT: 88%
Market capitalization -- DYN: $3.37B vs. PTCT: $5.46B
DYN [@Biotechnology] is valued at $3.37B. PTCT’s [@Biotechnology] market capitalization is $5.46B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green while PTCT’s FA Score has 1 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • PTCT’s FA Score: 1 green, 4 red.
According to our system of comparison, DYN is a better buy in the long-term than PTCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 5 TA indicator(s) are bullish while PTCT’s TA Score has 4 bullish TA indicator(s).

  • DYN’s TA Score: 5 bullish, 6 bearish.
  • PTCT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DYN is a better buy in the short-term than PTCT.

Price Growth

DYN (@Biotechnology) experienced а -9.67% price change this week, while PTCT (@Biotechnology) price change was -11.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.58%. For the same industry, the average monthly price growth was -18.26%, and the average quarterly price growth was -28.15%.

Reported Earning Dates

DYN is expected to report earnings on Mar 04, 2027.

PTCT is expected to report earnings on Feb 23, 2027.

Industries' Descriptions

@Biotechnology (-11.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
-3.31%
RNA - DYN
64%
Loosely correlated
-0.86%
RCKT - DYN
55%
Loosely correlated
-7.58%
EDIT - DYN
54%
Loosely correlated
-4.09%
STOK - DYN
54%
Loosely correlated
-0.45%
BCYC - DYN
54%
Loosely correlated
-4.92%
More

PTCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTCT has been loosely correlated with SLDB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PTCT jumps, then SLDB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCT
1D Price
Change %
PTCT100%
-3.27%
SLDB - PTCT
51%
Loosely correlated
-2.95%
DYN - PTCT
50%
Loosely correlated
-3.31%
DNLI - PTCT
48%
Loosely correlated
+1.37%
MGTX - PTCT
46%
Loosely correlated
-1.97%
ARQT - PTCT
45%
Loosely correlated
-2.98%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LGHT11.13N/A
N/A
Langar Global HealthTech ETF (LGHT)
FALN25.27-0.08
-0.32%
iShares Fallen Angels USD Bond ETF (FALN)
BAMD32.16-0.54
-1.64%
Brookstone Dividend Stock ETF (BAMD)
XAUG37.68-0.88
-2.28%
FT Vest U.S. Equity Enhance & Moderate Buffer ETF - August (XAUG)
BJAN56.07-1.68
-2.91%
Innovator U.S. Equity Buffer ETF - January (BJAN)